Phase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumors. [electronic resource]
Producer: 20120821Description: 656-69 p. digitalISSN:- 1552-4604
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Area Under Curve
- Benzenesulfonates -- administration & dosage
- Drug Administration Schedule
- Drug Interactions
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Israel
- Leucovorin -- administration & dosage
- Male
- Metabolic Clearance Rate
- Middle Aged
- Neoplasms -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- administration & dosage
- Pyridines -- administration & dosage
- Sorafenib
- Treatment Outcome
- Vitamin B Complex -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.